Long‐Term Effects of Sglt2 Deletion on Bone and Mineral Metabolism in Mice

Sodium‐glucose cotransporter 2 (SGLT2) inhibitors improve kidney and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM). However, bone fragility has emerged as a side effect in some but not in all human studies. Because use of SGLT2 inhibitors in humans affects mineral metaboli...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerber, Claire, Wang, Xueyan, David, Valentin, Quaggin, Susan E., Isakova, Tamara, Martin, Aline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328801/
https://www.ncbi.nlm.nih.gov/pubmed/34368611
http://dx.doi.org/10.1002/jbm4.10526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328801/
https://www.ncbi.nlm.nih.gov/pubmed/34368611
http://dx.doi.org/10.1002/jbm4.10526

Ejemplares similares